Clinical studies recruiting near Avignon

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 DVT Burden and the Risk of Post-thrombotic Syndrome
NA · Centre Hospitalier d'Avignon · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06385353 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Henri Duffaut Hospital · Poitiers University Hospital · NCT05686850 TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Institut Sainte-Catherine · NovoCure Ltd. · NCT06924099 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Ch D'Avignon - Hopital Henri Duffaut · Hospices Civils de Lyon · NCT05444712 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · CH d'Avignon - Hopital Henri Duffaut · The Lymphoma Academic Research Organisation · NCT06006117 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic C
Phase 2 · Institut du Cancer d'Avignon · UNICANCER · NCT06245356 Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma
Phase 3 · Institut Sainte Catherine · Federation Francophone de Cancerologie Digestive · NCT07270991 FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Phase 2 · CENTRE HOSPITALIER d'AVIGNON · Centre Leon Berard · NCT06393816 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Phase 2 · Ch D'Avignon · University Hospital, Lille · NCT05572229 Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
Phase 3 · Institut Sainte Catherine · UNICANCER · NCT04747054 Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Phase 2 · Sainte Catherine, Institut du Cancer Avignon-Provence · UNICANCER · NCT07661927 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Centre Hospitalier d'Avignon /ID# 275229 · AbbVie · NCT04928846 Interaction Between Intraventricular Flow and Cardiac Mechanics Using 3D Echocardiography in Athletes and Sedentary Subj
Phase N/A · LaPEC · University of Avignon · NCT07363993 COsegregation of VARiants in Panel of Genes
NA · Institut Sainte-Catherine · Institut Curie · NCT01689584 ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Pa
NA · Institut du cancer Avignon-Provence · Institut Curie · NCT05441163 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Institut Sainte Catherine · Daiichi Sankyo · NCT06731478 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced
Phase N/A · CH AVIGNON - CH Henri Duffaut - Réanimation polyvalente · Nantes University Hospital · NCT06780722 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0471 · Bristol-Myers Squibb · NCT06561386 Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Phase N/A · CH d Avignon - Hopital Henri Duffaut · The Lymphoma Academic Research Organisation · NCT04220970 CARE1 Pragmatic Clinical Trial
Phase 3 · Institut Sainte Catherine · Gustave Roussy, Cancer Campus, Grand Paris · NCT06364631 A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed No
Phase 3 · Centre hospitalier d'Avignon · ETOP IBCSG Partners Foundation · NCT06931717 Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NA · Sainte-Catherine - Institut du Cancer Avignon-Provence · Fundacio Clinic Barcelona · NCT06446882 Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy f
Phase 3 · Avignon Icap · Federation Francophone de Cancerologie Digestive · NCT06207981 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Sainte Catherine Institut du Cancer Avignon Provence · Eli Lilly and Company · NCT06119581 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Institut Sainte Catherine · Daiichi Sankyo · NCT06203210 Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma
Phase 3 · Institut Sainte Catherine · Gustave Roussy, Cancer Campus, Grand Paris · NCT06402864 Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stag
Phase 2 · Avignon - CH · Intergroupe Francophone de Cancerologie Thoracique · NCT06656598

Look up another city

Look up another condition